Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3

NCT00390559 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-07-18

Study results available
· View outcomes & findings →

Summary

Treatment studies have demonstrated that current smoking cessation techniques are less effective for women. The purpose of this study is to determine the role that gender plays in the effectiveness of nicotine replacement therapy. In addition, the purpose of this study is to determine whether men and women differ in their response to smoking-related stimuli (e.g., taste or smell of a lit cigarette). Conclusions drawn from this study may help to improve cessation interventions for all smokers, particularly women.

Conditions

  • Drug Addiction
  • Smoking Cessation

Interventions

DRUG

nicotine transdermal system

21 mg nicotine transdermal system

DRUG

Nicotine transdermal system

Placebo nicotine patch

OTHER

Nicotine containing cigarette

Nicotine containing cigarette

OTHER

Placebo cigarette

Non nicotine containing cigarette

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Thomas E Eissenberg, PhD · Virginia Commonwealth University Department of Psychology, Institute for Drug and Alcohol Studies

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00390559 on ClinicalTrials.gov